Clinical Trial

Phase II Study of THDBH120 Injection in Overweight or Obese Subjects

Name: Phase II Study of THDBH120 Injection in Overweight or Obese Subjects — clinical trial record (NCT07036601)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 2

View on ClinicalTrials.gov →

Record status

This record was last updated June 25, 2025 (before its estimated February 13, 2026 completion). Its status may not reflect the trial's current state.

Summary

To assess the efficacy and safety of THDBH120 injection compared with placebo in weight reduction in overweight or obese subjects after 26 weeks of treatment.

Trial Details

NCT Number	NCT07036601
Lead Sponsor	Tonghua Dongbao Pharmaceutical Co.,Ltd
Conditions	Overweight or Obese
Enrollment	276 participants
Start Date	2025-01-06
Primary Completion	2026-02-13 (estimated)
Study Completion	2026-03-11 (estimated)
Updated on ClinicalTrials.gov	2025-06-25